National Institute of General Medical Sciences (NIGMS)
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, National Institute of General Medical Sciences (NIGMS) sits in the top decile of US sponsors by registered trial count (#987 of 15,742 sponsors by registered trial count).
National Institute of General Medical Sciences (NIGMS): 14 sponsored US clinical trials, none currently recruiting.
National Institute of General Medical Sciences (NIGMS) sponsors 14 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 14 completed. 2 of these trials are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Severe Sepsis, with 1 trials.
Top-decile sponsor footprint
National Institute of General Medical Sciences (NIGMS) ranks in the top decile of sponsors by registered trial count (#987 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
14 of 14 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Indexed trials (enrollment closed)
14 total, page 1 of 1
H2O VR for Burns 2015
NCT02729259
Virtual Reality Pain Control Orthopedic Trauma
NCT02100163
Low Dose Ketamine VR Analgesia During Burn Care Procedure
NCT01889537
VR High Tech Pain Control Burn Wound Care
NCT02427659
Randomized Trial of Inhaled Nitric Oxide to Augment Tissue Perfusion in Sepsis
NCT00608322
Virtual Reality Analgesia During Pediatric Physical Therapy
NCT00993889
Clinical Trial of the Optimal Endpoint of Early Sepsis Resuscitation
NCT00372502
Bioelectric Field Imaging Near Human Skin Wounds
NCT00355823
Opiate-Induced Tolerance & Hyperalgesia in Pain Patients
NCT00246532
Continuous Femoral Nerve Block Following Total Knee Replacement
NCT00135889
Tamoxifen Pharmacogenetics and Clinical Effects
NCT00228930
Virtual Reality Pain Control During Burn Wound Care
NCT00261690
VRH Pain Reduction During Burn Wound Care and Physical Therapy
NCT00260221
Antidepressant Treatment of Mexican-Americans: UCLA Pharmacogenetics and Pharmacogenomics Research Group
NCT00265291
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 3 |
| Phase 3 | 1 |
| Phase 4 | 1 |
Therapeutic Areas
How the National Institute of General Medical Sciences (NIGMS) archive is shaped
14 indexed studies, none listed as recruiting (0% open); 14 completed (100%).
Phase mix: 2 late (III/IV) vs 3 early (I/II) (balanced across stages).
Top condition: Severe Sepsis (1 trial), 3 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
National Institute of General Medical Sciences (NIGMS): archived-pipeline peers nationwide
Peers matched on 14 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
National Institute of General Medical Sciences (NIGMS) sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 14 archived trials
- 3-C Institute for Social Development · 14 trials · 0% recruiting
- Abbott Medical Optics · 14 trials · 0% recruiting
- Abbott RDx Cardiometabolic · 14 trials · 0% recruiting
- Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA · 14 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3 Waves Wellness · 0% recruiting · 2 trials
Related
What to do with this National Institute of General Medical Sciences (NIGMS) page
14 registered trials is a research-attention snapshot, not an endorsement of National Institute of General Medical Sciences (NIGMS) or any single study.
- None of National Institute of General Medical Sciences (NIGMS)'s trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Severe Sepsis is the condition National Institute of General Medical Sciences (NIGMS) studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Severe Sepsis trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
National Institute of General Medical Sciences (NIGMS) pipeline card: 14 registered trials from official public datasets.Report a data error.